All Type of News


‘Zemiglo trial’ prolonged for a while, expected to take even longer

The Zemiglo license lawsuit between LG Chem(former LG Life Sciences) and Sanofi-Aventis has been prolonged due to several changes of date. On the 14th, the 17th Civil Division at the Seoul Central District Court deli...

Hospitals and clinics purchasing medicines less than KRW 30 billion exempted to obligated payment

Organizations purchasing medicines worth of less than KRW 3 billion a year, like hospitals and pharmacies, will have an exception to the payment obligation. The Ministry of Health and Welfare(Minister Neung-Hoo Park,...

Peak seasons for different medical departments

Different medical departments have a different season to have a crowd of patients. A department of ophthalmology gets busy with eye trouble patients during summer due to swimming, and a peak season for orthopedics is ...

Distribution association decides to take strong actions on MSD’s low-margin ‘Zepatier’

The pharmaceutical distribution industry has attracted attention as giving a notice of aggressive action to products with very low margins. The Korea Pharmaceutical Distribution Association held a Chairmen’s meeting ...

Medicine- or drug-related names can only be used by drug manufacturers or sellers from December

Every business owner, but pharmaceutical manufactures and sellers, will be imposed a fine for using a name similar to medicine and drug from the coming December. The Ministry of Food and Drug Safety gave a pre-announ...

Pharmas to control wholesalers over rebates through ‘CP’ and ‘Fair Trade Agreement’

While a pharmaceutical company started to intensively control its client wholesalers as part of the rebate eradication plan, it has been spread to other pharmaceutical companies. Recently, a pharmaceutical company se...

Registered medicines are now available to acquire separate approval as orphan drug

In order to promote manufacturing of orphan drugs, a system will be improved for already registered medicines to acquire separate product approval as am orphan drug. The Minister of Food and Drug Safety(Minister Youn...

Loopholes of preferential sale approval system causes damages on pharmas

Loopholes of the preferential sale approval system, which was implemented to shorten times to commercialize generics drugs by nullifying an original product’s patent, have caused delays for generics to be launched eve...

Eased responsibilities for challenging research failures

In order to promote R&D, the government will ease responsibilities for failures, but tighten restrictions on repeated wrongful uses of R&D expenses. The Ministry of Trade, Industry and Energy(Minister Woon-Kyu Baek, ...

Kolon Life Science conducts overseas marketing services to attract foreign patients for ‘Invossa’

Kolon Life Science(CEO Woo-Seok Lee) announced on the 13th that the company signed a strategic MOU for Invossa K Inj to attract foreign patients with the Korea Medical Tourism Promotion Association(President Chun-Ki J...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.